IDEAYA Biosciences, Inc. (IDYA) Cash Flow Statement
IDEAYA Biosciences, Inc. (IDYA) generated -$111.7M of operating cash flow over the twelve months to 2026-06-30, spent $2.2M on capital expenditure and had free cash flow of -$113.9M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
IDYAIDEAYA Biosciences, Inc.Follow IDYA — free
—
Price chart with a free account
- Market cap
- 3.3B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 0.06 | -0.06 | -0.09 | -0.12 | -0.25 | -0.07 | -0.11 | |
| Capital expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | |
| Free cash flow | 0.05 | -0.06 | -0.09 | -0.12 | -0.25 | -0.07 | -0.11 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | |
| Stock-based compensation | 0.00 | 0.01 | 0.01 | 0.02 | 0.03 | 0.05 | — |
USD billions · SEC XBRL
IDEAYA Biosciences, Inc. — questions
- What is IDEAYA Biosciences, Inc.'s operating cash flow?
- -$111.7M over the twelve months to 2026-06-30.
- How much does IDEAYA Biosciences, Inc. spend on capital expenditure?
- $2.2M over the twelve months to 2026-06-30.
- What is IDEAYA Biosciences, Inc.'s free cash flow?
- -$113.9M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from IDEAYA Biosciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.